MIRA Pharmaceuticals (NASDAQ:MIRA) | WebDisclosure

Basculer en Français

10064	Companies
205717	Keywords
135956	Articles
109065	Press releases

Home
Companies
MIRA Pharmaceuticals

PRESS RELEASE

published on 07/22/2024 at 14:00, 1 year 8 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders

Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRIEF

published on 07/15/2024 at 13:05, 1 year 8 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRIEF

published on 07/15/2024 at 13:05, 1 year 8 months ago

Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC

Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
PRESS RELEASE

published on 07/15/2024 at 13:00, 1 year 8 months ago

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects

Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders

Accesswire

Published on 03/23/2026 at 12:20, 2 minutes ago

Guanajuato Silver Adds Veteran Mine Operator to Board of Directors
Published on 03/23/2026 at 12:15, 7 minutes ago

Snipp Interactive Secures US$3 Million Contract, Largest in Company History
Published on 03/23/2026 at 12:00, 22 minutes ago

Churchill Consolidates High-Grade Gold-Antimony Footprint in Central Newfoundland; Enters Option for 100% of Golden Baie
Published on 03/23/2026 at 11:30, 52 minutes ago

Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 4 hours 22 minutes ago

ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 11:44, 37 minutes ago

Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:30, 52 minutes ago

EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 1 hour 15 minutes ago

Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 1 hour 16 minutes ago

ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 1 hour 17 minutes ago

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Les Echos

Published on 03/23/2026 at 08:10, 4 hours 12 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 17 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 18 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 18 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE